Author

U. Baumgartner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

B. W. Day· 2 shared B. Wainwright· 2 shared A. Kordowski· 1 shared A. Perren· 1 shared B. Sharf Den Abu Fakher· 1 shared C. Lim· 1 shared C. Nydegger· 1 shared C. Offenhauser· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. W. Day

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Spatial Transcriptomic Sequencing of a DIPG-infiltrated Brainstem reveals Key Invasion Markers and Novel Ligand-Receptor Pairs contributing to Tumour to TME Crosstalk

A. Kordowski, O. Mulay, X. Tan, T. Vo, U. Baumgartner, M. K. Maybury, T. E. G. Hassall, B. Wainwright, L. Harris, Q. Nguyen, B. W. Day

This study uses spatial transcriptomics to analyze a DIPG-infiltrated brainstem, identifying invasion markers and ligand-receptor pairs involved in tumour-TME crosstalk.

bioRxiv · May 7, 2024 · PreprintCancer Biology

Unlocking the potential of miR-19b in the regulation of temozolomide response in glioblastoma patients via targeting PPP2R5E, a subunit of the protein phosphatase 2A complex

E. Kashani, K. Hlavackova, S. Haemmig, M. C. Sadowski, J. Phour, U. Baumgartner, N. Mueller-Wirth, C. Trefny, B. Sharf Den Abu Fakher, C. Nydegger, T. Maragkou, P. Schucht, A. Perren, P. Zinn, M. Luedi, , E. Vassella

This study identifies miR-19b's role in TMZ resistance in GBM by targeting PPP2R5E, showing that miR-19b attenuation enhances TMZ efficacy in cell lines and xenografts.

bioRxiv · Jan 16, 2023Cancer Biology

Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids

Y. Li, T. Dismuke, C. Lim, Z. C. Bruce, C. Offenhauser, U. Baumgartner, M. Maybury, R. C. J. DSouza, T. Hassall, B. Wainwright, G. Stein, M. Piper, T. G. Johns, M. Sokolsky-Papkov, T. R. Gershon, B. W. Day

This study shows that targeting OLIG2 with CT-179 reduces recurrence in SHH medulloblastoma models and improves survival when combined with radiotherapy.

bioRxiv · Feb 14, 2022 · PreprintCancer Biology